Clinical trial investigating CBD for opioid addiction gets underway
The first patient has been enrolled in the trial in what has been described as a “key milestone”.
24 results for “addiction”
The first patient has been enrolled in the trial in what has been described as a “key milestone”.
Adolescents were more vulnerable to addiction, but were no more likely to have higher levels of depression or anxiety.
We sit down with the recently-appointed medical director of The Medical Cannabis Clinics, Dr Luisa Searle.
Brains Bioceutical is partnering with a clinical research organisation in the US to undertake the study.
It is hoped the trial will help to reduce the number of opioid deaths in the US
A new study shows that CBD may help with chewing tobacco addiction by controlling certain symptoms.
A new study adds to the growing body of research exploring the potential use of cannabis in reducing opioid dependency. Following in the footsteps of North America, the UK is […]
A new study will explore the effect of a unique CBD technology on reducing opioid consumption in chronic pain patients. US biotech pharma company, ANANDA have announced a second clinical […]
CBD may not be an effective way to reduce cocaine dependence, but researcher’s have not ruled out the potential of cannabis-based medicines. There are over 19 million cocaine users globally, […]
Campaigners in Ireland have raised concerns after cannabis was compared to heroin and crack cocaine by a leading addiction specialist. Education around cannabis is ‘sorely lacking’ in Ireland according to […]
Cannabis-derived molecules could help relieve chronic pain without the psychoactive effects associated with THC.
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
After two years of Germany’s Cannabis Act (CanG), the most comprehensive analysis of its impact to date has been published.
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
Early findings on the impact of the partial legalisation of cannabis suggest no short-term spike in consumption or drug-driving.
Researchers say the new thresholds – modelled on alcohol units – could help people avoid potentially harmful consumption.
Dr Simon Erridge reflects on some of the key findings published on medical cannabis this year.
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study. The study, published […]
Findings highlighting the relationship between trauma, THC and paranoia have prompted calls for improved patient monitoring.
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, […]
Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.
But over half were concerned about the negative impact of stigma associated with cannabis.
James Smith, co-founder of 4C Labs, shares his recent experience using cannabis-based medicines after a hip replacement.